Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results (Standalone) Of The Company For The Quarter Ended On June 30 2026
06-Aug-2026 | Source : BSEGenomic Valley Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve unaudited financial results (standalone) of the Company for the quarter ended on June 30 2026.
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
06-Jul-2026 | Source : BSECertificate under Regulation 74 (5) of SEBI (DP) Regulations 2018 for the quarter ended on 30th June 2026.
Closure of Trading Window
29-Jun-2026 | Source : BSEClosure of trading window.
Corporate Actions
14 Aug 2026
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available